Biofarma Group Acquired US Pharma Lab Creating the First Global CDMO Fully Focused on Nutraceuticals
US Pharma Lab, headquartered in North Brunswick, NJ, is a global and innovative company and a custom developer, manufacturer, and supplier of premium dietary supplement ingredients, premixes, and products.
Earlier this month, Biofarma Group, the new Italian and European CDMO (Contract Development and Manufacturing Organization) market leader in developing, manufacturing, and packaging medical devices, acquired US Pharma Lab. Gianfranco Nazzi, CEO of Biofarma Group commented:
“We are delighted to partner with Amol and the US Pharma Lab team. The combination of Biofarma Group and US Pharma Lab will create the only global CDMO fully focused on Nutraceuticals, which will be able to offer significant additional benefits to new and existing customers through a broad range of nutraceutical technologies and R&D capabilities, in addition to providing a harmonized service globally”.
We are honored to have advised US Pharma Lab on this transaction. Please read the press release here.
